A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : FLS / fatty liver Shionogi

[Related PubMed/MEDLINE]
Total Number of Papers: 25
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   FLS  (>> Co-occurring Abbreviation)
Long Form:   fatty liver Shionogi
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Gene Expression Analysis of the Activating Factor 3/Nuclear Protein 1 Axis in a Non-alcoholic Steatohepatitis Mouse Model. ATF3, CHOP, ER, NAFLD/NASH, NUPR1, TUNEL
2019 Protective Effects of Ipragliflozin, a Sodium-glucose Cotransporter 2 Inhibitor, on a Non-alcoholic Steatohepatitis Mouse Model. ER, NASH
2016 A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model. miRNAs, NAFLD, NASH, SS
2016 Antifibrotic effects of ambrisentan, an endothelin-A receptor antagonist, in a non-alcoholic steatohepatitis mouse model. TIMP-1
2015 Bile acid binding resin improves hepatic insulin sensitivity by reducing cholesterol but not triglyceride levels in the liver. LXR
2014 Novel effect of ezetimibe to inhibit the development of non-alcoholic fatty liver disease in Fatty Liver Shionogi mouse. MTP, NAFLD
2014 Therapeutic effects of the direct renin inhibitor, aliskiren, on non-alcoholic steatohepatitis in fatty liver Shionogi ob/ob male mice. ATII, DRI, NASH, PRA, RAS
2013 Fatty liver Shionogi-ob/ob mouse: A new candidate for a non-alcoholic steatohepatitis model. ---
2013 Iridal coloboma induces dyscoria during miosis in FLS mice. ---
10  2013 The FLS (fatty liver Shionogi) mouse reveals local expressions of lipocalin-2, CXCL1 and CXCL9 in the liver with non-alcoholic steatohepatitis. DS, NAFLD, NASH, qRT-PCR
11  2012 Organogenesis of mild ocular coloboma in FLS mice: failure of basement membrane disintegration at optic fissure margins. PAS
12  2012 Therapeutic effects of angiotensin II type 1 receptor blocker, irbesartan, on non-alcoholic steatohepatitis using FLS-ob/ob male mice. AT, NASH
13  2011 [Organs related to glucose metabolism and aging in animal models]. NSY
14  2010 Insulin resistance, steatohepatitis, and hepatocellular carcinoma in a new congenic strain of Fatty Liver Shionogi (FLS) mice with the Lep(ob) gene. NASH, ob
15  2010 Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model. MTP, NAFLD, NASH, TG, VLDL
16  2010 Regulatory effects of Y4 receptor agonist (BVD-74D) on food intake. ---
17  2009 A novel mouse model for type 2 diabetes and non-alcoholic fatty liver disease: spontaneous amelioration of diabetes by augmented beta cell mass. NAFLD
18  2007 High sensitivity of fatty liver Shionogi (FLS) mice to diethylnitrosamine hepatocarcinogenesis: comparison to C3H and C57 mice. DEN, NASH
19  2006 A newly established mutant strain with mild-type ocular coloboma (retinochoroidal coloboma without microphthalmia) in albino mice. GD
20  2006 Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver. NAFLD, PPAR
21  2003 A novel type hypertriglyceridemia observed in FLS mice. apo, LPL
22  2003 Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. PP
23  2003 Expression of hepatoma-derived growth factor in hepatocarcinogenesis. HCC, HDGF
24  2003 Spontaneous development of hepatocellular carcinomas in the FLS mice with hereditary fatty liver. HCC
25  1999 The FLS mouse: a new inbred strain with spontaneous fatty liver. DS